Gland Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '25
Dec '24
Sep '24
Jun '24
Mar '24
Total Qtr Revenue cr
1,468.94
1,442.55
1,465.49
1,453.14
1,579.60
Other Income Qtr Cr44.0358.4959.6651.4342.15
Operating Revenues Qtr1,424.911,384.051,405.831,401.711,537.45

*All values are in Cr.

Operating Expenses Qtr
1,077.39
1,024.10
1,108.78
1,137.31
1,178.80
Operating Profit Qtr
347.52
359.96
297.06
264.40
358.65
EBITDA Qtr Cr
391.54
418.45
356.72
315.82
400.80
Depreciation Qtr
95.76
96.32
93.83
91.96
92.61
Net Profit Qtr
186.54
204.69
163.53
143.76
192.42
Basic EPS Qtr
11.32
12.42
9.93
8.73
11.68
Open Demat Account
+91 -

Open Demat Account
+91 -